Is diabetes the cost to pay for a greater cardiovascular prevention?

International Journal of Cardiology

Volumn 144, Issue 2, 2010, Pages 309-310

  Rizzo, Manfredi ^a   Spinas, Giatgen A ^b   Rini, Giovam Battista ^a   Berneis, Kaspar ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Atherosclerosis; Cardiovascular risk; Diabetes; Prevention; Statins

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; UBIQUINONE;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES MELLITUS; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; LETTER; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 77957852862     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.001     Document Type: Article

References (6)

1. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-421. 23.
2. P.M. Ridker, E. Danielson, and F.A.H. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
3. J. Sasaki, M. Iwashita, and S. Kono Statins: beneficial or adverse for glucose metabolism J Atheroscler Thromb 13 2006 123 129
4. H.K. Berthold, A. Naini, and S. Di Mauro Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial Drug Saf 29 2006 703 712
5. M.A. Kawashiri, A. Nohara, and H. Tada Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study Clin Pharmacol Ther 83 2008 731 739
6. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150